All In Biotech

Free tool

FAERS Monitor: Admelog

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 209196 or its brand name (Admelog, Insulin Lispro). Reports on generic versions are filed under their own applications.

Reports

14,537

Serious

8,838

61% of reports

Hospitalization

5,398

Death reported

990

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased2,450
  • incorrect dose administered887
  • drug ineffective835
  • hypoglycaemia676
  • visual impairment634
  • nausea606
  • dyspnoea575
  • off label use508
  • product dose omission issue507
  • blood glucose decreased477
  • vomiting447
  • diarrhoea436
  • fatigue424
  • acute kidney injury411
  • headache391

Reports by year received

View as table
YearReports
200461
200560
200638
200744
200865
200974
201079
201174
2012109
2013131
2014194
2015279
2016292
2017325
2018707
2019926
20201,415
20211,460
20221,568
20231,638
20241,648
20251,955
20261,395

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,039,622 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypoglycaemiaSignal67620.419.012,331
blood glucose increasedSignal2,45019.018.441,710
blood glucose decreasedSignal47714.513.35,939
visual impairmentSignal6347.46.93,528
incorrect dose administeredSignal8875.65.33,405
acute kidney injurySignal4113.93.5885
product dose omission issueSignal5072.52.3459
dyspnoea5751.51.488
vomiting4471.41.347
nausea6061.11.07
diarrhoea4361.00.90
drug ineffective8350.90.97
headache3910.90.84
off label use5080.80.816
fatigue4240.80.725

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.